Related Experiment Video
Updated: Apr 6, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Hepatitis C infection and chronic renal diseases
1Departamento de Clínica Médica da Disciplina de Moléstias Infecciosas, Grupo de Estudo das Hepatites Virais, Universidade Estadual de Campinas (Unicamp), Campinas, Brazil. aline.vigani@sigmanet.com.br.
Insights
Hepatitis C virus (HCV) infection can cause kidney disease, and end-stage renal disease patients are more likely to get HCV. Management guidelines are lacking due to limited research.
Area of Science:
- Nephrology
- Hepatology
- Infectious Diseases
Background:
- Hepatitis C virus (HCV) infection and chronic renal diseases share a complex bidirectional relationship.
- HCV can precipitate certain renal diseases, while end-stage renal disease (ESRD) patients face heightened risk of HCV acquisition.
- Co-occurrence of chronic HCV and renal disease is associated with poor patient prognosis.
Purpose of the Study:
- To review current insights into Hepatitis C virus infection as an extrahepatic manifestation.
- To explore HCV infection as a complication in patients with end-stage renal disease.
- To highlight the need for evidence-based management strategies for this dual condition.
Main Methods:
- Review of existing literature on HCV infection and renal diseases.
- Analysis of studies focusing on HCV as an extrahepatic manifestation.
- Examination of research concerning HCV in end-stage renal disease patients.
Main Results:
- Limited uncontrolled trials with small sample sizes characterize current research.
- A significant lack of evidence-based recommendations and clinical guidelines exists.
- The interplay between HCV and renal pathology requires further investigation.
Conclusions:
- The management of patients with concurrent HCV infection and renal disease lacks robust guidelines.
- Further well-designed studies are crucial to establish effective treatment protocols.
- Understanding HCV's role in renal disease and vice versa is critical for improving patient outcomes.
Abstract:
Hepatitis C virus (HCV) infection and chronic renal diseases can be linked in two different ways. Some forms of renal disease are precipitated by HCV infection, while patients with end-stage renal disease are at increased risk for acquiring HCV infection. Patients with chronic HCV infection and renal disease have a poor prognosis. Most studies on treatment of HCV and renal diseases have been uncontrolled trials with small number of subjects. So, there is a lack of evidence-based recommendations and guidelines on the management of this condition. In this review, we will attempt to provide the most recent insights on HCV infection both as a extrahepatic manifestations and as a complication of end-stage renal patients.
Related Concept Videos
Hepatitis
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic Kidney Disease I: Introduction
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Chronic Kidney Disease III: Interprofessional Care

